| Literature DB >> 35956548 |
Aras Türkoğlu1, Kamil Haliloğlu2,3, Özge Balpinar4, Halil Ibrahim Öztürk5, Güller Özkan6, Peter Poczai7,8.
Abstract
Mammalian sex hormones are steroid-structured compounds that support the growth and development of plants at low concentrations. Since they affect the physiological processes in plants, it has been thought that mammalian sex hormones may cause modifications to plant genomes and epigenetics. This study aims to determine whether different mammalian sex hormones (17 β-estradiol, estrogen, progesterone, and testosterone) in several concentrations (0, 10-4, 10-6, and 10-8 mM) affect genetic or epigenetic levels in bean plants, using in vitro tissue cultures from plumule explants. We investigated levels of DNA damage, changes in DNA methylation and DNA stability in common bean exposed to mammalian sex hormones (MSH) using inter-primer binding site (iPBS) and Coupled Restriction Enzyme Digestion-iPBS (CRED-iPBS) assays, respectively. The highest rate of polymorphism in iPBS profiles was observed when 10-4 mM of estrogen (52.2%) hormone was administered. This finding indicates that genetic stability is reduced. In the CRED-iPBS profile, which reveals the methylation level associated with the DNA cytosine nucleotide, 10-4 mM of estrogen hormone exhibited the highest hypermethylation value. Polymorphism was observed in all hormone administrations compared to the control (without hormone), and it was determined that genomic stability was decreased at high concentrations. Taken together, the results indicate that 17 β-estradiol, estrogen, progesterone, and testosterone in bean plants affect genomic instability and cause epigenetic modifications, which is an important control mechanism in gene expression.Entities:
Keywords: CRED-iPBS; epigenetics; genotoxic; in vitro
Year: 2022 PMID: 35956548 PMCID: PMC9370127 DOI: 10.3390/plants11152071
Source DB: PubMed Journal: Plants (Basel) ISSN: 2223-7747
Molecular sizes (bp) of present/absent bands in iPBS profiles after application of different MSHs and different concentrations in treated Phaseolus vulgaris L. under tissue culture conditions.
| iPBS Primer | *+/- ** | Control *** | Experimental Groups | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 17 β-Estradiol | Progesterone | Testosterone | Estrogen | |||||||||||
| 10−8 mM | 10−6 mM | 10−4 mM | 10−8 mM | 10−6 mM | 10−4 mM | 10−8 mM | 10−6 mM | 10−4 mM | 10−8 mM | 10−6 mM | 10−4 mM | |||
| 2075 | + | 6 | - | 689; 590 | 590 | 590 | - | 590 | - | 571 | 461 | 454 | - | 447 |
| - | - | - | - | - | - | - | - | - | - | - | - | - | ||
| 2077 | + | 6 | - | 379 | 920; 918; 659; 467; 372 | 940; 843; 379 | 950; 925; 857; 475; 379 | 950; 875; 900; 475 | - | 491; 379 | 960; 850 | 491 | 960; 880; 483; 386 | 900; 850 |
| - | 813; 700; | - | - | - | - | - | - | - | 311 | - | - | - | ||
| 2087 | + | 4 | - | - | 900; 452; 416 | - | 425 | 900; 480 | - | - | 940 | 960; 320 | 980; 960; | 1320 |
| - | - | - | - | 831; 500 | - | 727; 648 | 831; 500 | 831; 727; 500 | 727; 648; 500 | - | 727 | 831; 727 | ||
| 2278 | + | 9 | - | 950 | 900; 950 | 1357 | 920; 800; 750 | 1357 | 920; 800 | 920 | 920; 800 | 920; 800 | 920; 900 | 920; 800; 750 |
| - | 752; 520 | 520 | - | 752 | - | 520 | - | 520 | 752; 400; 310 | 520; 382 | - | 752; 664; 400; 310 | ||
| 2375 | + | 10 | - | 1371 | 1371; 970; 852; 536 | 1357 | 975; 885; 800; 757; 725; 575 | 957 | 975; 985; 857 | 971 | 975; 885 | 957; 900; 814 | 985; 885 | 985; 914; 828 |
| - | 779; 607 | 607 | - | 779 | - | 607 | - | 607 | 779; 718; 486; 308 | 607; 382 | - | 779; 718; 664; 422; 382 | ||
| 2377 | + | 9 | - | - | - | - | - | - | - | - | 985 | - | - | - |
| - | 957; 970; 710; 582; 431 | 970; 582; 487; 431 | 431 | 900; 710; 637; 582; 520; 487; 431 | 487; 431 | 582; 487; 431 | 710; 487; 431 | 487; 431 | 487; 431 | 431 | 582; 487; 431 | 970; 582 | ||
| 2380 | + | 5 | - | 548 | - | - | 1060; 920 | 1060; 837 | 858; 560 | 940; 858 | - | 879; 783 | 980; 950; 900 | 940; 837 |
| - | - | - | - | - | - | - | - | - | - | - | - | - | ||
| 2381 | + | 9 | - | - | - | - | - | - | - | - | - | - | - | - |
| - | 900; 850; 833; 420; 376 | 900; 850; 972; 833 | 472; 376 | 972; 376 | 472; 376 | 950; 900; 872; 472; 420; 324 | 900; 833; 472; 376 | 900; 850; 822; 800; 651; 472; 420; 376 | 900; 850; 833; 472; 376 | 900; 651; 420; 376; 324 | 972; 833; 651; 472; 376; 324 | 900; 822; 783; 651; 472; 420; 376; 324 | ||
| 2382 | + | 6 | 936 | - | 917 | - | 1040; 413 | 1000 | - | - | - | - | - | 917; 809 |
| - | - | - | - | 521 | - | 521 | 521 | 589; 500 | 870; 589; 521 | 521 | - | - | ||
| 2384 | + | 5 | - | 525; 239 | - | - | - | - | - | - | - | 759; 553 | 711; 543; 361 | - |
| - | 282 | - | 800 | 282 | - | - | 392; 282 | - | - | - | - | 800 | ||
| Total band | 69 | 18 | 18 | 20 | 21 | 23 | 26 | 19 | 24 | 30 | 24 | 26 | 36 | |
| Polymorphism (%) | 26.1 | 26.1 | 29 | 30.4 | 33.3 | 37.7 | 27.5 | 34.8 | 43.5 | 34.8 | 37.7 | 52.2 | ||
| GTS value (%) | 73.9 | 73.9 | 71 | 69.6 | 66.7 | 62.9 | 72.5 | 65.2 | 56.5 | 65.2 | 62.9 | 47.8 | ||
*, ** and ***; appearance of a new band, disappearance of a normal band and without hormone, respectively.
Figure 1iPBS profiles for various experimental groups with 2075 primers in bean M; 100–1000 bp DNA ladder, 1; control (MS without any hormone) 2; MS medium containing 10−8 mM 17-β-estradiol, 3; MS medium containing 10−6 mM 17-β-estradiol, 4; MS medium containing 10−4 mM 17-β-estradiol, 5; MS medium containing 10−8 mM progesterone, 6; MS medium containing 10−6 mM progesterone, 7; MS medium containing 10 4 mM progesterone, 8; MS medium containing 10−8 mM testosterone, 9; MS medium containing 10−6 mM testosterone, 10; MS medium containing 10−4 mM testosterone, 11; MS medium containing 10−8 mM estrogen, 12; MS medium containing 10−6 mM estrogen, 13; MS medium containing 10−4 mM estrogen.
Results of CRED-iPBS analysis; molecular size of bands and polymorphism percentage.
| iPBS Primer | M*/H ** | +***/- **** | Control ***** | Experimental Groups | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 17 β-Estradiol | Progesterone | Testosterone | Estrogen | ||||||||||||
| 10−8 mM | 10−6 mM | 10−4 mM | 10−8 mM | 10−6 mM | 10−4 mM | 10−8 mM | 10−6 mM | 10−4 mM | 10−8 mM | 10−6 mM | 10−4 mM | ||||
| 2075 | M | + | 7 | - | - | - | - | - | 347 | - | - | - | 626 | - | - |
| - | - | - | 393 | - | - | - | - | - | - | - | 271 | 393 | |||
| H | + | 7 | - | - | - | - | - | 376 | - | - | - | 315 | - | - | |
| - | 400 | 393; 271 | - | - | - | - | 400 | - | - | - | 400 | 266; 180 | |||
| 2077 | M | + | 6 | 916; 883; 750 | 816; 700; 618 | 465 | 916; 812 | 933; 866; 850; 716 | 950; 866;800; 750; 718 | 916; 900; 918 | 950; 816; 733; 718; 465 | - | 933; 900; 833; | 933; 800 | 916; 860; 800; 613;491; 377 |
| - | 356; 318 | 318 | - | 318 | - | - | 415; 312 | - | 356; 318 | - | 312 | - | |||
| H | + | 6 | 818 | 1413; 1016 | 933; 850; 718 | 916; 916; 838 | 933;816 | 933; 833; 718 | 933; 1050 | 950; 923; 936 | 950; 900; 800 | 916; 816; 780 | 933; 850; 884; 800; 780; 739 | 933; 866; 716 | |
| - | - | 415; 312 | 575; 415; 356; 312 | - | 312 | 600 | 318 | - | - | 415; 312 | - | 415; 318 | |||
| 2087 | M | + | 7 | - | - | 522; 400; 350 | - | 1675 | - | - | - | - | - | - | - |
| - | 922; 815; 700; 567; 500 | 1125; 922; 815; 629; 567; 418 | 1300; 1075 | 975; 922; 815; 700; 600; 489 | 922; 815; 629; 567; 500 | 975; 922; 815; 529; 567 | 950; 875; 822; 700; 600; | 900; 875; 815 | 925; 822; 815; 700; 629; 500 | 925; 922; 815;700; 629; 418 | 900; 875; 822; 815; 700; 600 | 975; 822; 715; 700; 600 | |||
| H | + | 8 | 900; 427 | - | - | 320 | - | - | - | 950 | 320 | - | - | - | |
| - | - | 975; 922; 815; 600; | 975; 922; 815; 700; 489 | 900; 815 | 900; 875; 815 | 925; 629; 418 | 925; 822; 815; 629; 567; 418 | 700; 567; 418 | 900; 805; 722; 615 | 900; 875; 822; 700; 600 | 815; 567; 500; 418 | 925; 822; 815; 629; 567; 418 | |||
| 2278 | M | + | 8 | - | - | 500 | - | - | 1475 | - | - | - | - | - | - |
| - | 925; 760 | 825;465 | 900; 900 | 900; 750; 650; 450 | 955; 900; 465 | 925; 900; 760 | 900; 800; 750; 450 | 850; 800 | 925; 900; 760 | - | 900; 800;715; 750 | 900; 815; 750; 450 | |||
| H | + | 5 | 950; 427 | - | - | 310 | - | - | - | 950 | - | - | - | - | |
| - | - | 900; 815 | 900; 815; 750; 450 | 900; 815 | 900; 900; 815 | 925; 465 | 760; 465 | 760; 465 | 900; 700 | 950; 900; 750 | 925; 760; 465 | 1125; 760 | |||
| 2375 | M | + | 5 | 920; 589 | 920 | 940 | 900; 866 | 1000; 579 | 900; 820; 747; 589 | 837 | 900; 851; 811 | 980; 920; 661; 589; 454 | 980; 920; 651; 589 | 824; 326 | 851 |
| - | - | - | - | - | - | - | - | - | - | - | - | - | |||
| H | + | 4 | - | 938; 811 | - | 837; 700 | 880; 851; 700 | 840; 589; 468 | 920; 454 | 880; 760; 589 | 851; 737; 700 | - | 900; 820; 589 | 920; 680; 365 | |
| - | 866;811; 709 | - | 405 | - | - | - | 709 | - | - | - | - | - | |||
| 2377 | M | + | 6 | 1262 | 1287 | 640; 583; 492; 338; 264 | 913 | 887; 1125 | 1312 | 926 | 964; 739; 682; 632 | - | - | 912 | 975; 839; 762; 648; 616; 492 |
| - | 431; 394 | 431; 394 | - | - | 500; 394 | - | - | - | 729; 500; 394 | - | 400 | - | |||
| H | + | 6 | - | 987 | - | - | 739 | 1262 | - | 860; 1087; 762 | - | 1100 | 975; 887 | 975 | |
| - | - | 548 | - | - | - | 431; 394 | 431 | - | 885; 827; 453; 400 | - | - | 729; 500 | |||
| 2380 | M | + | 5 | 607; 500 | 1000; 555 | - | 732; 607; 568; 450 | 541 | 889 | 607 | 607 | - | 944; 527 | 912 | 944; 880; 613; 580 |
| - | - | - | - | - | - | - | - | - | 846; 400 | - | - | - | |||
| H | + | 5 | - | 961 | 875; 607; 527 | 600 | 944 | 600; 500 | - | 673 | 912; 591 | - | 981 | 591 | |
| - | - | 400 | - | - | - | - | 400 | 846 | - | - | - | - | |||
| 2381 | M | + | 5 | - | - | - | - | - | 900; 724; 550 | - | 925; 900; 750; 334 | - | - | 325; 269 | - |
| - | 611 | 819; 353 | - | 833; 466 | 819 | - | 921; 633; 537 | - | 811; 611 | 819; 427; 353 | 921; 633 | 466 | |||
| H | + | 4 | - | - | - | - | 900; 679 | - | 925; 800; 679 | - | - | - | - | ||
| - | - | 537; 466; 409 | 537 | 633 | 921; 633; 537 | - | 427 | - | 633; 537; 466; 409 | 921; 633; 466; 409 | - | 819; 427; 353 | |||
| 2382 | M | + | 4 | - | - | 753; 529 | 586; 369 | - | - | - | 916; 848 | - | - | - | 545 |
| - | 645 | - | - | - | 753; 645; 537 | 940; 753 | 492 | - | 940; 753; 645 | 940; 753; 645; 537 | - | - | |||
| H | + | 8 | - | - | 408 | - | - | - | - | - | - | 529 | - | - | |
| - | 940 | - | - | 900 | 645 | 753; 645 | 940; 537 | 940; | 645 | - | 940; 753 | 940; 537 | |||
| 2384 | M | + | 8 | - | - | - | - | - | - | - | - | - | 700; 480 | - | - |
| - | 958 | 958; 408 | 958; 830; 540; 461; 391; 346 | 958; 830 | 958 | 958; 276 | 958; 461; 346 | 958; 346 | 958; 276 | - | 958; 346; 281 | 830; 461; 346 | |||
| H | + | 6 | - | - | - | - | - | - | 461 | - | - | - | - | 920; 452 | |
| - | 958; 830; 551; 408 | - | - | 958; 346; 281 | 958; 540; 461; 346 | - | - | 958 | 958; 346; 281 | - | 958; 830 | - | |||
| Polymorphism % | M | 37.3 | 37.3 | 39.3 | 41 | 44.1 | 47.5 | 39.3 | 42.6 | 47.5 | 42.4 | 42.6 | 52.5 | ||
| H | 23.7 | 32.8 | 36.1 | 27.9 | 36.1 | 37.3 | 35.6 | 39 | 44.3 | 29.51 | 41 | 41.2 | |||
*, **, ***, **** and *****; M—Msp I, H—Hpa II, appearance of a new band, disappearance of a normal band and without hormone, respectively.
Figure 2CRED-RA profiles for various experimental groups with OPH-17 primers in bean. M; 100–1000 bp DNA ladder,1; control (MS without any hormone) Msp I 2; control (MS without any hormone) Hpa II, 3; MS medium supplemented with 10−8 mM 17-β-estradiol Msp I, 4; MS medium supplemented with 10−8 mM 17-β-estradiol Hpa II, 5; MS medium supplemented with 10−6 mM 17-β-estradiol Msp I, 6; MS medium supplemented with 10−6 mM 17-β-estradiol Hpa II, 7; MS medium supplemented with 10−4 mM 17-β-estradiol Msp I, 8; MS medium supplemented with 10−4 mM 17-β-estradiol Hpa II, 9; MS medium supplemented with 10−8 mM progesterone Msp I, 10; MS medium supplemented with 10−8 mM progesterone Hpa II, 11; MS medium supplemented with 10−6 mM progesterone Msp I, 12; MS medium supplemented with 10−6 mM progesterone Hpa II, 13; MS medium supplemented with 10−4 mM progesterone Msp I, 14; MS medium supplemented with 10−4 mM progesterone Hpa II, 15; MS medium supplemented with 10−8 mM testosterone Msp I, 16; MS medium supplemented with 10−8 mM testosterone Hpa II, 17; MS medium supplemented with 10−6 mM testosterone Msp I, 18; MS medium supplemented with 10−6 mM testosterone Hpa II, 19; MS medium supplemented with 10−4 mM testosterone Msp I, 20; MS medium supplemented with 10−4 mM testosterone Hpa II, 21; MS medium supplemented with 10−8 mM estrogen Msp I, 22; MS medium supplemented with 10−8 mM estrogen Hpa II, 23; MS medium supplemented with 10−6 mM estrogen Msp I, 24; MS medium supplemented with 10−6 mM estrogen Msp I, 25; MS medium supplemented with 10−4 mM estrogen Hpa II, 26; MS medium supplemented with 10−4 mM estrogen Msp I.
Sequence information of 10 iPBS primers and their annealing (Ta) temperatures.
| Primer Name | Sequence (5′–3′) | Tm (°C) | CG (%) |
|---|---|---|---|
| iPBS-2075 | CTCATGATGCCA | 42.1 | 50 |
| iPBS-2077 | CTCACGATGCCA | 46.1 | 58.3 |
| iPBS-2087 | GCAATGGAACCA | 43.5 | 50 |
| iPBS-2278 | GCTCATGATACCA | 42.3 | 46.2 |
| iPBS-2375 | TCGCATCAACCA | 45.1 | 50 |
| iPBS-2377 | ACGAAGGGACCA | 47.2 | 58.3 |
| iPBS-2380 | CAACCTGATCCA | 41.4 | 50 |
| iPBS-2381 | GTCCATCTTCCA | 40.9 | 50 |
| iPBS-2382 | TGTTGGCTTCCA | 44.9 | 50 |
| iPBS-2384 | GTAATGGGTCCA | 40.9 | 50 |